The activity of meropenem and comparators against Acinetobacter strains isolated from European hospitals, 1997–2000
- 1 June 2003
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 9 (6) , 563-567
- https://doi.org/10.1046/j.1469-0691.2003.00591.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The increasing role of Acinetobacter species as nosocomial pathogensCurrent Infectious Disease Reports, 2001
- Emerging Importance of Multidrug‐ResistantAcinetobacterSpecies andStenotrophomonas maltophiliaas Pathogens in Seriously Ill Patients: Geographic Patterns, Epidemiological Features, and Trends in the SENTRY Antimicrobial Surveillance Program (1997–1999)Clinical Infectious Diseases, 2001
- Nosocomial Bloodstream Infections Caused by Acinetobacter Species in United States Hospitals: Clinical Features, Molecular Epidemiology, and Antimicrobial SusceptibilityClinical Infectious Diseases, 2000
- MYSTIC (Meropenem Yearly Susceptibility Test Information Collection): a global overview.Journal of Antimicrobial Chemotherapy, 2000
- Antibiotic Susceptibility Among Aerobic Gram-negative Bacilli in Intensive Care Units in 5 European CountriesJAMA, 1999
- In vitro activity of meropenem against common pathogenic bacteria isolated in TaiwanDiagnostic Microbiology and Infectious Disease, 1998
- Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactamThe Lancet, 1994
- Antimicrobial susceptibility of Acinetobacter speciesAntimicrobial Agents and Chemotherapy, 1993
- Association of contaminated gloves with transmission of Acinetobacter calcoaceticus var. anitratus in an intensive care unitThe American Journal of Medicine, 1991
- Multiple intensive care unit outbreak of Acinetobacter calcoaceticus subspecies anitratus respiratory infection and colonization associated with contaminated, reusable ventilator circuits and resuscitation bagsThe American Journal of Medicine, 1988